Consumers in China are taking to social media to express their support for Huawei as the U.S. government looks to ramp up pressure on the Chinese smartphone maker.Technologyread more
U.S. President Donald Trump's latest tariff increase — and Beijing's plans to counter them — are hitting U.S. companies in China, according to a joint survey this month by...China Economyread more
"We are also constantly watching whether the trade war will turn into a tech war," Ma said Tuesday, according to a CNBC translation of his Chinese remarks published by a locak...China Economyread more
TransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.Technologyread more
Kohl's, J.C. Penney and Nordstrom release disappointing earnings news, putting a damper on their sector.Retailread more
Bezos's comments give a rare glimpse into his interest in the auto industry. Amazon recently invested in two self-driving start-ups.Technologyread more
While investing often seems like a contrarian game where going against the flow feels like the better bet, the reality is that investors who bought the most-favored stocks...Hedge Fundsread more
The economist thinks the Fed ought to pay more attention to financial markets when setting interest rates.The Fedread more
U.S. Trade Representative Robert Lighthizer will meet with officials from the European Union and Japan at the ministerial meeting of the Organization for Economic Co-operation...World Economyread more
Talks between the world's two largest economies have stalled after each nation lobbied higher tariffs on the other's imports.Traderead more
"Pretty much the entire suite of apps that 'talk' over the internet could be vulnerable," said Tom Uren, a senior analyst at the Australian Strategic Policy Institute's...Cybersecurityread more
Bayer on Monday was ordered by a Northern California jury to pay more than $2 billion to a couple who say they were diagnosed with cancer after using the company's glyphosate-based weedkiller Roundup.
Shares of Bayer were down 5.9% in early trading on Tuesday.
The San Francisco Superior Court in Oakland said the company had to pay the plaintiffs, Alva and Alberta Pilliod, the damages after they contracted non-Hodgkin's lymphoma. Alva Pilliod was awarded a total of $1.37 billion, while his wife Alberta was granted $1.18 billion.
The jury said the company's product did not properly warn of its cancer risk.
Bayer said in a statement it was disappointed with the jury's decision and planned to appeal, adding that it "conflicts directly" with the Environmental Protection Agency's finding that there are "no risks to public health from the current registered uses of glyphosate."
"We have great sympathy for Mr. and Mrs. Pilliod, but the evidence in this case was clear that both have long histories of illnesses known to be substantial risk factors for non-Hodgkin's lymphoma (NHL), most NHL has no known cause, and there is not reliable scientific evidence to conclude that glyphosate-based herbicides were the 'but for' cause of their illnesses as the jury was required to find in this case," the company said.
A spokesman also said: "Bayer believes the punitive verdict is excessive and unjustifiable."
This is the third lawsuit the company has lost related to claims that Roundup causes cancer. Bayer paid $159 million in damages in the first two cases. The company said it would appeal both verdicts. There are more than 13,400 lawsuits against Bayer set to go to trial in the United States related to the claims.
Roundup is a herbicide produced by Monsanto, which Bayer acquired last year for $63 billion. The company has denied allegations that its product causes cancer, saying that decades of studies and regulatory evaluations have shown the weedkiller to be safe for use.
Monsanto did not immediately respond to CNBC's request for comment.
—Reuters contributed to this report.